Presentation Transcript
Diabetes Mellitus : Diabetes Mellitus Barbara S. Hays
Winter, 2006
Blood Glucose(normal serum level 65 – 105 mg) : Blood Glucose (normal serum level 65 – 105 mg)
Inside CNS
Brain uses glucose as primary fuel
Brain cannot store/produce glucose
Outside CNS
Fatty acids: stored as
Glycogen (liver/muscles)
Triglycerides (fat cells)
Blood glucose, cont. : Blood glucose, cont. Outside CNS, continued
Endocrine portion of pancreas: Islets of Langerhans
Alpha cells make glucagon
“counterregulatory”, acts opposite of insulin
Beta cells make insulin
Allows body cells to store and use carbohydrate, fats, and protein
Hyperglycemia : Hyperglycemia When blood glucose becomes high
INSULIN allows glucose to enter cells
Liver
Production /storage of glycogen
Inhibits glycogen breakdown
Increased protein & fat synthesis (VLDL formation)
Muscles
Promotes protein and glycogen synthesis
Fat cells
Promotes storage of triglycerides
Hyperglycemia : Hyperglycemia
Drowsy
Flushed
Thirsty
Hypoglycemia : Hypoglycemia Glucagon: causes release of glucose from liver
“glycogenolysis (breakdown of glycogen to glucose)
“glyconeogenesis of glucose not available
Lipolysis (breakdown of fat)
Proteolysis (breakdown of amino acids)
Hypoglycemia : Hypoglycemia
Weak, sweaty
Confused/irritable/ disoriented
Diabetes Mellitus(problem with glucose metabolism) : Diabetes Mellitus (problem with glucose metabolism) Major health problem US/worldwide
Complications [lousy blood vessels]
Blindness
Renal failure
Amputations
[heart attacks and strokes]
[OB/neonatal complications]
Diabetes Mellitus : Diabetes Mellitus
The good news:
Blood glucose control reduces complications of Diabetes!
Diabetes Mellitus : Diabetes Mellitus Absence (or ineffectiveness of ) insulin
Cellular resistance
Cells can’t use glucose for energy
Starvation mode
Compensatory breakdown of body fat/protein
Ketone bodies from faulty fat breakdown
Metabolic acidosis, compensatory breathing (Kussmal’s breathing)
Diabetes Mellitus : Diabetes Mellitus HYPERGLYCEMIA: fluid/electrolyte imbalance.
Polyuria
Sodium, chloride, potassium excreted
Polydipsia from dehydration
Polyphagia: cells are starving, so person feels hungry despite eating huge amounts of food. Starvation state remains until insulin is available.
Diabetes Mellitus : Diabetes Mellitus Complications of chronic hyperglycemia
Macrovascular complications
Cardiovascular disease (heart attack)
Cerebrovascular disease (strokes)
Microvascular
Blindness (retinal proliferation, macular degeneration)
Amputations
Diabetic neuropathy (diffuse, generalized, or focal)
Erectile dysfunction
Classifying Diabetes Mellitus : Classifying Diabetes Mellitus
Type I Diabetes: autoimmune
Beta cell destruction in genetically susceptible person
Some viral infections
Classifying Diabetes Mellitus : Classifying Diabetes Mellitus
Type II Diabetes
Reduction in ability of most cells to respond to insulin
Poor control of liver glucose output
Decreased beta-cell function (eventual failure)
Diabetes Mellitus : Diabetes Mellitus Major risk factors
Family history
Obesity
Origin (Afro-American, Hispanic, Native American, Asian-American)
Age (older than 45)
History of gestational diabetes
High cholesterol
Hypertension
Diabetes Mellitus : Diabetes Mellitus Prevention of effects: combination approach
Increased exercise
Decreases need for insulin
Reduce calorie intake
Improves insulin sensitivity
Weight reduction
Improves insulin action
Triad of Treatment : Triad of Treatment
Diet
Medication
Oral hypoglycemics
Insulins
Exercise
Diabetes treatment : Diabetes treatment
Exercise
Under physician supervision
Check glucose prior
Diabetes treatment : Diabetes treatment
Diet
Lower calorie
Fewer foods of “high glycemic index”
Spread meals evenly
Diabetes treatment : Diabetes treatment Anti-Diabetic medications
Oral hypoglycemic agents (“Easy” p 297)
Sulfonylureas
Thiazolidinediones
Biguanides
Alpha-glucosidase inhibitors
D-phenylalinine derivatives
Combinations
Insulins (“Easy” Prototype Pro p 393)
Sulfonylureas : Sulfonylureas Stimulate pancreas to secrete insulin
Glyburide (Diabeta) [Prototype Pro p 393]
Glucotrol (Glipizide)
Diabenese (chlorpropamide)
Adverse reactions
Hypoglycemia
Water retention/edema
Photosensitivity
May need to add insulin in times of stress
Biguanides : Biguanides Decreases liver production of glucose
Decreases intestinal absorption of glucose
Improves cell sensitivity to insulin
Example: Metformin
GI upset, flatulence
Cardiac (CHF, MI)
Thiazolidinediones : Thiazolidinediones Increase cellular sensitivity to insulin
Pioglitazone (Actos)
Rosiglitazone (Avandia)
Client should have liver enzymes
checked periodically
D-Phenylalanine derivatives : D-Phenylalanine derivatives
Nateglinide (Starlix)
Rapid onset, short half-life
Good for those with rapid post prandial rise in blood glucose
Combinations : Combinations Glucovance
Glyburide and Metformin
Avandamet
Avandia and Metformin
[come tell me when you run into this question…]
Insulin : Insulin
Made in beta cells of the pancreas
Moves glucose into cells (thus acts like growth hormone in a way)
Moves potassium into cells (can buy time in emergencies)
Insulin preparations (“Easy” p 390)given ONLY with syringes marked in “units” : Insulin preparations (“Easy” p 390) given ONLY with syringes marked in “units”
Rapid acting (lispro, asparte)
Short acting (regular)
Intermediate acting (NPH)
Long acting
Ultralente
[Glargine/Lantus]
Your learning : Your learning
Onset of action
Peak (blood glucose will be lowest then)
Duration
Rapid acting insulin : Rapid acting insulin Lispro (Humolog, Novolog Aspart)
Onset of action
“15-30” minutes [may come on in 5 minutes…]
Peak of action
1 - 2 hours
Duration
3 – 4 hours
Short acting insulins : Short acting insulins Regular (clear so can be given IV)
Onset of action
0.5 to 1 hour
Peak of action
2 – 4 hours
Duration of action
6 – 8 hours
Intermediate acting insulins : Intermediate acting insulins NPH, Lente (chemicals added. Cloudy)
Onset of action
1 – 4 hours
Peak of action
4 – 12 hours
Duration of action
18 – 24 hours
Long acting insulins : Long acting insulins Ultralente
Onset of action
4 – 8 hours
Peak of action
18 hours
Duration of action
24 – 36 hours
Once a day insulin : Once a day insulin Glargine/Lantus
Cannot be diluted or mixed in syringe with any other insulin
Slow, steady release
Daily dosing [usually at bedtime]
Refrigerated or tosses every 14 days
Combination insulins : Combination insulins 70/30 (70% NPH and 30% regular)
Humolog 70/30 (Humolog and regular)
Fewer injections
Rotate sites to decrease lipodystrophy
Miscellaneous : Miscellaneous Byetta for type II Diabetics taking sulfonylureas or combination
Mimics physiologic glucose control
Inhances insulin secretion only in presence of hyperglycemia
Insulin secretion decreases as blood glucose approaches normal
Neutontin for Diabetic nerve pain
Some things to know : Some things to know
Insulin moves potassium into cells
Good for emergency situations
Dangerous if potassium level already low
Some things to know… : Some things to know… HHNK (Hyperglycemic Hyperosmolar Non-Ketotic Coma). Also called
HHNK
HNKS [syndrome]
Like dibetic ketoacidosis, without the ketones
Type II diabetic, makes enough insulin to avoid ketones, but sugar guilds up to dangerous levels -> cellular dehydration
Some things to know… : Some things to know…
Dawn Phenomenon vs Somogi’s effect
Dawn phenomenon
Blood sugar rises in early morning
Somogi’s (rebound) effect
Blood sugar rise in morning as reaction to hypoglycemic time during the night
Some things to know… : Some things to know…
Diabetic foot care
Dry, cracked skin + poor circulation could = loss of a limb
For the most part nurses don’t trim nails of diabetic clients. Refer to Podiatrist.
Typical diabetic foot ulcer : Typical diabetic foot ulcer
Catch the
buzz on authorSTREAM
Copyright © 2002-2008 authorSTREAM. All rights reserved.